Cyclacel Pharmaceuticals to Present at Biotech Showcase 2024
BERKELEY HEIGHTS, N.J., Jan. 02, 2024 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC, NASDAQ:CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, announced today that Spiro Rombotis, President & Chief Executive Officer, will present an overview of its business and provide updates on its clinical programs at Biotech Showcase, taking place January 8-10, 2024 in San Francisco, California.
Related news for (CYCC)
- Plogosertib Shows Promise in Biliary Tract Cancer with BUBR1 as Potential Biomarker
- MoBot’s Stock Market Highlights – 07/23/25 01:00 PM
- Breaking News: MoBot’s Latest Update as of 07/23/25 12:00 PM
- Breaking News: MoBot’s Latest Update as of 07/18/25 11:00 AM
- MoBot’s Stock Market Highlights – 07/18/25 10:00 AM